Diversified Healthcare Trust
DHC · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.18 | 0.13 | 0.00 |
| FCF Yield | 2.19% | -0.56% | 3.30% | 10.84% |
| EV / EBITDA | 57.29 | 48.68 | 50.70 | 74.30 |
| Quality | ||||
| ROIC | 42.92% | 21.29% | 1.15% | 14.41% |
| Gross Margin | 18.31% | 18.74% | 16.91% | 17.02% |
| Cash Conversion Ratio | – | -0.58 | 0.36 | -0.21 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.54% | 4.04% | 4.65% | 5.22% |
| Free Cash Flow Growth | 680.91% | -117.82% | -83.28% | 3,203.61% |
| Safety | ||||
| Net Debt / EBITDA | 42.69 | 39.62 | 42.27 | 54.09 |
| Interest Coverage | 1.16 | 1.10 | 1.06 | 0.84 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 16.40 | 16.27 | 0.96 | 17.85 |